Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) EPS (Basic) (2020 - 2025)

SOPHiA GENETICS's EPS (Basic) history spans 6 years, with the latest figure at -$4.15 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 24.75% to -$4.15 in Q4 2025 year-over-year; TTM through Dec 2025 was -$35419.3, a 243020.47% decrease, with the full-year FY2025 number at -$15.78, down 10.07% from a year prior.
  • EPS (Basic) hit -$4.15 in Q4 2025 for SOPHiA GENETICS, up from -$4.47 in the prior quarter.
  • Over the last five years, EPS (Basic) for SOPH hit a ceiling of -$0.23 in Q4 2022 and a floor of -$35406.8 in Q2 2025.
  • Historically, EPS (Basic) has averaged -$4439.7 across 5 years, with a median of -$3.91 in 2025.
  • Biggest five-year swings in EPS (Basic): skyrocketed 99.98% in 2022 and later crashed 963699.64% in 2025.
  • Tracing SOPH's EPS (Basic) over 5 years: stood at -$0.41 in 2021, then soared by 44.27% to -$0.23 in 2022, then crashed by 64.43% to -$0.37 in 2023, then tumbled by 794.89% to -$3.33 in 2024, then dropped by 24.75% to -$4.15 in 2025.
  • Business Quant data shows EPS (Basic) for SOPH at -$4.15 in Q4 2025, -$4.47 in Q3 2025, and -$35406.8 in Q2 2025.